The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.
E M Smets, B Garssen, B Bonke...
https://pubmed.ncbi.nlm.nih.gov/7636775Actively Recruiting
Led by Texas Christian University · Updated on 2026-01-14
68
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether the Alii Supplement can reduce symptoms related to nutritional depletion in women who use hormonal birth control pills. The study focuses on improvements in happiness, digestive health, mood swings, perceived vulnerability to disease, and energy levels. This randomized, double-blind trial involves 68 female university students aged 18 to 25 who have been on hormonal birth control for at least six months. Participants will be randomly assigned to take either the Alii Supplement or a placebo daily for 28 days. Each participant takes three capsules per day, with or without food, and receives daily reminders to help with adherence. The Alii Supplement contains multiple vitamins and nutrients aimed at addressing nutritional depletion, while the placebo contains inactive ingredients. After 28 days, participants complete follow-up surveys to assess changes in the targeted symptoms. Throughout the study, participants will fill out online surveys at the start and end of the 28-day period to measure happiness, mood swings, digestive health, vulnerability to disease, and energy. The research team will compare these measures before and after supplement use to see if the Alii Supplement has an effect. The study includes two visits to the research office for survey completion, and participants are monitored for their adherence to taking the capsules.
CONDITIONS
Alii Supplement Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 28 days
Participants take either the Alii supplement or a placebo daily for 28 days. They will receive daily reminders to take their capsules and complete surveys about their symptoms before and after treatment.
1 baseline visit and 1 follow-up visit
Total: 1 location
1
Texas Christian University
Fort Worth, Texas, United States, 76109
Actively Recruiting
S
Sarah E Hill, PhD
M
Melissa M Brillhart
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
E M Smets, B Garssen, B Bonke...
https://pubmed.ncbi.nlm.nih.gov/7636775Stephen Joseph, P Alex Linley, Jake Harwood...
https://pubmed.ncbi.nlm.nih.gov/15588455Joohyun Yoon, Tae Hyon Ha, Sunghee Oh...
https://pubmed.ncbi.nlm.nih.gov/34441044